Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Rosario Pardo Diaz

Rosario Pardo Diaz

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca
Rosario Pardo Diaz

Rosario Pardo Diaz

Rosario Pardo Diaz

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Neuroprotección en la retinopatía diabética: una nueva estrategia terapéutica

IP: Rafael Simó Canonge
Collaborators: Rosario Pardo Diaz, Patricia Bogdanov Baruj, Laura Natalia Distefano
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 187200
Reference: SAF2012-35562
Duration: 01/01/2013 - 31/12/2015

Mecanismos moleculares de la restricción calórica en tejido adiposo blanco

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz, Rosario Pardo Diaz
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 75020
Reference: SAF2011-23886
Duration: 01/01/2012 - 30/06/2013

Ministerio de Ciencia

Papel del coactivador PGC-1 beta en tejido adiposo blanco y su contribución al desarrollo de la obesidad y la diabetes de tipo 2

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 168190
Reference: SAF2008-03644
Duration: 01/01/2009 - 31/03/2012

Ministerio de Ciencia

Related news

Professionals que han format part de l'elaboració de la guia

Contribution to a guideline on resmetirom and semaglutide for fatty liver disease

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

Presentació de la guia per al tractament farmacològic de l'obesitat al Congrés Europeu d'Obesitat

We participate in the creation of guidelines to improve care for patients with obesity

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

Dra. Andreea Ciudin

A clinical trial shows the efficacy and safety of a drug for type 2 diabetes and obesity

The study evaluates elecoglipron and shows improvements in glycemic control and body weight compared with placebo.

See more

Related professionals

Martí Municoy Terol

Martí Municoy Terol

Technological Infrastructure Unit
Digital Transformation Directorate
Read more
Maria Jose Herrero Mata

Maria Jose Herrero Mata

Postdoctoral researcher
Transfusional Medicine
Read more
Víctor García García

Víctor García García

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Joaquin Temprado Piqueras

Joaquin Temprado Piqueras

Junior researcher
Maternal and Fetal Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.